Emergency Room Visits and Older Patients (ER2) (ER2)

Emergency Room Visits and Older Patients: Assessment of Jewish General Hospital Program Screening Frail Users

Today's population is living longer than prior generations. Senior patients, defined as 65 years or older, are therefore increasing in number, and representing a larger number of hospitalized patients. Thus, assessing and addressing the needs of the growing number of older ER users is essential. The overall objective of the study is to examine the feasibility and the epidemiology of two screening tools ("Programme de Recherche sur l'Intégration des Services pour le Maintien de l'Autonomie" (PRISMA-7) and Emergency Room Evaluation and recommendations (ER2)) used in the Emergency Room of Jewish General Hospital to screen older patients (i.e.; ≥65 years) at risk of adverse health events. A prospective observational cohort design will be used for the study's two phases; phase 1- assessment and phase 2- assessment as well as recommendations.

Study Overview

• Status: Completed
• Conditions: Emergencies; Length of Stay
• Intervention / Treatment: Other: ER assessment

• Study Type: Observational
• Enrollment (Actual): 356

Contacts and Locations

Study Locations

• Canada
  • Quebec
    • Montréal, Quebec, Canada, H3T 1E2
      • Jewish General Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 65 years and older (Older Adult)
• Accepts Healthy Volunteers: N/A

• Sampling Method: Non-Probability Sample

Study Population

They will be separated in four main groups:

1. Those without any PRISMA-7 and ER2.
2. Those with PRISMA-7 and without ER2.
3. Those with ER2 and without PRISMA-7.
4. Those with PRISMA-7 and ER2. Each group of participants with PRISMA-7 and ER2 will be divided in two subgroups: those with all items completed and a score, and those with incomplete tools.

Description

Inclusion Criteria:

• Age ≥ 65 years.
• Unplanned ER visits.

Exclusion Criteria:

• Death within the 24 hours of first visiting ER.
• Palliative care due to ER visit.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Feasibility of using both tools in the ER	Percentage of participants with complete filed tools (older patients with tools filed / (older patients visiting the ER) x 100) will be calculated.	1 day
Prevalence of tools filed	Prevalence will be calculated for PRISMA-7, ER2 and pooled tools respectively.	1 day

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Feasibility of tools	Estimation of quality of filling using the percentage of items filled in for participants with an incomplete tool.	1 day
Length of stay	The LHS will be calculated using the administrative registry of the JGH and will correspond to the delay in days between the first day of admission to ED and the last day of hospitalization in the acute ward(s).	1 day
Acute medical events	Acute medical events occurring during the period of the ER visit and admission to the medical or surgery ward (acute organ failure, nosocomial infection, fall or death)	1 day

Collaborators and Investigators

• Sponsor: Jewish General Hospital
• Investigators: Principal Investigator: Olivier Beauchet, Jewish General Hospital - Lady Davis Institute

Publications and helpful links

General Publications

• Beauchet O, Afilalo M, Allali G, Lubov J, Galery K, Launay CP. "Emergency Room Evaluation and Recommendations" and Incident Hospital Admissions in Older People with Major Neurocognitive Disorders Visiting Emergency Department: Results of an Experimental Study. Dement Geriatr Cogn Disord. 2022;51(3):291-296. doi: 10.1159/000524533. Epub 2022 May 12.

Study record dates

Study Major Dates

• Study Start (Actual): September 1, 2017
• Primary Completion (Actual): September 1, 2021
• Study Completion (Actual): July 1, 2024

Study Registration Dates

• First Submitted: August 9, 2018
• First Submitted That Met QC Criteria: August 13, 2018
• First Posted (Actual): August 16, 2018

Study Record Updates

• Last Update Posted (Actual): July 23, 2024
• Last Update Submitted That Met QC Criteria: July 22, 2024
• Last Verified: July 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Emergencies
• Other Study ID Numbers: CODIM-16 315

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No